PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer

BACKGROUND: Immune checkpoint inhibition is effective in several cancers. Expression of programmed death-ligand 1 (PD-L1) on circulating tumor or immune effector cells could provide insights into selection of patients for immune checkpoint inhibition. METHODS: Whole blood was collected at serial tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Darga, Elizabeth P., Dolce, Emily M., Fang, Fang, Kidwell, Kelley M., Gersch, Christina L., Kregel, Steven, Thomas, Dafydd G., Gill, Anoop, Brown, Martha E., Gross, Steven, Connelly, Mark, Holinstat, Michael, Cobain, Erin F., Rae, James M., Hayes, Daniel F., Paoletti, Costanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592410/
https://www.ncbi.nlm.nih.gov/pubmed/34780566
http://dx.doi.org/10.1371/journal.pone.0260124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592410/
https://www.ncbi.nlm.nih.gov/pubmed/34780566
http://dx.doi.org/10.1371/journal.pone.0260124

Ejemplares similares